The S&P 500's 1.4% rise in January 2026 aligns with a decades-old market indicator, the 'January Barometer,' which historically signals strong full-year performance. Analysis of the past 40 years shows an 80% probability of gains through December following a positive January.
CNBC's Jim Cramer scrutinizes Bitcoin's sharp retreat from the $80,000 milestone, casting doubt on the durability of its support and highlighting a market driven more by narrative than fundamentals.
Despite a cautious market outlook, shareholders of Hong Leong Industries Berhad have seen their investments nearly triple over the past five years, driven by robust earnings growth and consistent dividends.
The business intelligence firm, the world's largest corporate holder of Bitcoin, is now sitting on nearly $1 billion in paper losses after the cryptocurrency's recent slump below its average acquisition cost, raising questions about its high-stakes treasury strategy.
Oracle Corporation announced a massive $45-50 billion fundraising plan for 2026, aiming to aggressively expand its cloud infrastructure to meet surging demand from leading AI and tech giants.
Boston Scientific's latest earnings beat and raised guidance, fueled by strong demand for its electrophysiology devices, signal a strategic shift. The company is navigating tariff pressures while expanding margins, with major acquisitions poised to reshape its long-term profile.
The FDA has cleared Intuitive Surgical's latest robotic system for use in certain heart surgeries, marking a strategic expansion into one of healthcare's largest and most complex service lines and potentially reshaping hospital capital planning for robotics.
A fresh price target for Euronext Brussels-listed IT services firm Econocom Group has analysts and investors reassessing the company's trajectory. The update reflects evolving views on the company's strategic positioning and market conditions.
Palantir Technologies expands its strategic footprint in Asia through a deepened partnership with HD Hyundai, while securing a pivotal role in building sovereign AI data centers across Europe, the Middle East, and Africa with Sovereign AI and Accenture.
While the FTSE 100 grapples with global headwinds, a segment of smaller UK-listed companies presents distinct opportunities. We examine three firms, each with a market capitalisation over £90 million, that combine financial resilience with specific growth catalysts.
Investors in German B2B specialist TAKKT AG (ETR:TTK) have faced a punishing three years, with total shareholder returns plummeting 68%. As revenue declines and the share price continues to slide, we examine the fundamentals behind the downturn and what it signals for the company's future.
At 77, Jane Perry's £2 million ISA portfolio stands as a testament to a simple, disciplined investment strategy begun in the 1980s. Her story challenges the gender investment gap and offers a blueprint for long-term wealth building.
As gold and silver surged to record highs last month, Bitcoin's puzzling stagnation below $90,000 had traders searching for answers. A closer look at exchange order books reveals a deliberate play by large players to suppress price—a tactic that ultimately set the stage for last week's sharp decline.
Kuya Silver reports a record quarterly production haul from its Bethania silver mine alongside accelerated underground development, drawing investor focus. However, a premium valuation against a backdrop of ongoing losses presents a complex picture for the junior miner.
Cardiac monitoring specialist iRhythm has finalized a significant corporate restructuring, creating a new parent company to serve as its publicly listed entity on Nasdaq. The move is seen as a strategic step to streamline governance and provide operational flexibility as the company expands its AI-driven health platform.
Travere Therapeutics faces a securities fraud investigation by Robbins Geller Rudman & Dowd LLP, raising questions about the accuracy of its past disclosures. The probe casts a shadow over the company's critical transition, as it banks on its kidney drug FILSPARI to drive growth amid mounting legal and commercial pressures.
Advanced Energy Industries (AEIS) transitions from the S&P 600 to the S&P 400 index, a move that reflects its evolving market stature and is set to alter its visibility among institutional investors and index-tracking funds.
Tripadvisor and Best Western's new AI-driven travel platform for the 2026 FIFA World Cup showcases the company's potential in high-stakes tourism. Yet, for investors, the real test remains translating innovation into sustained growth and market-beating returns.
Despite a 25% drop in earnings per share, Coronation Fund Managers (JSE:CML) delivered a robust 57% total shareholder return over the past year, driven by revenue growth and strong market sentiment, outperforming the broader South African market.
A sharp correction in Bitcoin prices has pushed MicroStrategy's massive holdings into significant paper losses, testing the resolve of the corporate sector's most vocal crypto advocate and raising questions about the sustainability of its accumulation strategy.
